Related Experiment Video

Updated: Jun 17, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

STAT1/2 is involved in the inhibition of cell growth induced by U0126 in HeLa cells

L Y Zhao1, C Huang, Z F Li

  • 1Department of Genetics and Molecular Biology, Medical School, Xi'an Jiaotong University/Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Shaanxi, PR China.

Cellular and Molecular Biology (Noisy-Le-Grand, France)
|December 17, 2009
PubMed

Insights

Targeting MAPK1 inhibits HeLa cell growth and induces apoptosis by upregulating STAT1/2. The MEK inhibitor U0126 affects ERK1/2 and STAT1/2, revealing crosstalk in cell signaling.

Area of Science:

  • Cell Biology
  • Molecular Signaling
  • Cancer Research

Background:

  • The mitogen-activated protein kinase (MAPK) pathway is crucial for cellular functions.
  • The crosstalk between the ras-raf-ERK1/2 and JAK-STAT pathways is not well understood.

Purpose of the Study:

  • To investigate the relationship between ERK1/2 and STAT1/2 signaling in HeLa cells.
  • To elucidate the role of STAT1/2 in MAPK-mediated cell growth inhibition and apoptosis.

Main Methods:

  • Utilized small interfering RNAs targeting MAPK1.
  • Employed MEK inhibitor U0126 and JAK-2 inhibitor AG490.
  • Analyzed cell growth, cell cycle, apoptosis, and protein expression/phosphorylation (ERK1/2, STAT1/2).

Main Results:

  • U0126 inhibited HeLa cell growth, arrested the cell cycle, and induced apoptosis.
  • U0126 modulated ERK1/2 activity and increased STAT1/2 expression and phosphorylation.
  • AG490 partially reversed U0126 effects, inhibiting STAT1/2 phosphorylation.

Conclusions:

  • STAT1/2 signaling is involved in the inhibition of HeLa cell growth induced by U0126.
  • There is a significant crosstalk between ERK1/2 and STAT1/2 pathways in HeLa cells.

More Related Videos

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...